Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

JPH records net income of $0.76 million in Q1 2019


According to the financial statements of Jerusalem Pharmaceuticals JPH for the 1st Quarter of 2019, Net profit after tax of the period reached 759,253 USD Compared with Net profit after tax 1,188,800 USD for 2018, a net decrease in profit of 36.13%.Total assets of the company reached 65,062,252 USD compared with total assets of 63,203,684 USD at the end of year 2018, a net increase of 2.94%.Total liabilities of the company reached 12,155,934 USD compared with total liabilities of 11,683,624 USD at the end of year 2018, a net increase of 4.04%. Net ownership equity of the company reached 52,906,318 USD (Including Non-Controlling Interests of 2,897,428 USD) compared with total owner equity of 51,520,060 USD (Including Non-Controlling Interests of 2,977,441 USD) at the end of year 2018, a net increase of 2.69%.



PID posts net income of JD0.65 million in 9M 2021

NAPCO posts net income of JD0.34 million in 9M 2021

RSR posts net income of JD0.31 million in 9M 2021

APC records net income of JD0.82 million in 9M 2021

ARAB posts net income of JD0.02 million in 9M 2021

Al-Quds Index in a narrow range amid an increase in 9M financial data disclosures anticipation

PHARMACARE recommends distributing 10% cash dividends for the year 2020

A transaction on the stocks of TRSUT raises the trading value in the PEX

Al-Quds Index rebounds upwards in the first week of October



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013